First randomised trial backs safety of common heart drugs in COVID-19 patients
Tuesday, September 1, 2020 - 14:30
in Health & Medicine
Heart patients hospitalized with COVID-19 can safely continue taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), according to new research.